Teradyne
About Teradyne   |   Investors   |   Careers   |   Contact   |   Teradyne.com
  Search
 
News & Events
Press Room
Press Home & Contact
Product Photos
Press Releases
Awards
Newsletter
Events
 
 
Request a Sales Call ?
 
Assembly Test & Inspection Solutions
News & Events
GenRad Board of Directors Approves Repurchase of Additional 2.5 Million Shares
 
Westford, Massachusetts -- January 31, 2000 -- GenRad, Inc. (NYSE: GEN) today announced that its Board of Directors has authorized the repurchase of an additional 2.5 million shares of GenRad common stock, bringing the total number of shares approved for repurchase to 5 million, or approximately 17% of the issued and outstanding common stock of the Corporation. As of January 1, 2000 the Company had repurchased a total of 2,044,600 shares.

The Company plans to purchase the shares in the open market and/or in private transactions. The number of shares purchased and the timing of purchases will be based on several conditions, including the price of GenRad stock and general market conditions.

James F. Lyons, Chairman and CEO, stated "By approving the additional stock repurchase the Board of Directors has cleared the way for us to strengthen the value of the stock our investors currently hold and to create a more attractive opportunity for others to buy or increase holdings. We are committed to protecting the integrity of the Company and our stockholders’ investment."

GenRad Background

GenRad, Inc. provides electronics OEMs and their customers with the hardware, software and services to increase productivity by optimizing product design, manufacturing and after-market service. GenRad, headquartered in Westford, MA, offers products and services through three business units: Advanced Diagnostic Solutions (ADS), Electronic Manufacturing Solutions (EMS), and GR Software (GRS). GenRad’s web site address is http://www.genrad.com.

GenRad’s most current shareholder information is available by visiting our Website at http://www.genrad.com or calling our Fax on Demand Service at (800) 469-1261.

Statements made in this press release which are not historical, including statements regarding future performance, product capabilities and markets are forward looking statements and as such are subject to a number of risks. Factors that may cause results to differ materially from those projected are discussed in GenRad’s 1998 Annual Report on Form 10-K for the fiscal year.

Learn More
   Contact Us
   Request Information
   Resource Center
   eKnowledge Login
   Training at Teradyne